Modulation of serum histamine releasing activity in chronic idiopathic urticaria

被引:7
作者
Zweiman, B [1 ]
Valenzano, M [1 ]
Atkins, PC [1 ]
机构
[1] Univ Penn, Sch Med, Med Ctr,Dept Med, Div Allergy & Immunol, Philadelphia, PA 19104 USA
来源
IMMUNOPHARMACOLOGY | 1998年 / 39卷 / 03期
关键词
urticaria; histamine; modulation; basophils Fc epsilon R; D2O; IL-3; anti-IgE;
D O I
10.1016/S0162-3109(98)00020-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background-Sera of about 30% of patients with chronic idiopathic urticaria (CIU) have increased histamine releasing activity (HRA(+)) on normal basophils. It is not known whether other CIU sera would be HRA(+) if a more sensitive histamine release assay was used. Although most HRA(+) CIU sera appear to have anti Fc epsilon R1 activity, it is not known whether post-binding basophil intracellular events are similar to those after anti-IgE stimulation. Results-In the presence of D2O, the HR stimulated by 28 previously documented HRA(-) sera increased from 4 +/- 0.4 to 21 +/- 4% with 13 of the 28 sera now considered HRA(+). No previous HRA(-) sera was HRA(+) with IL-3 treated cells. Histamine release induced by both HRA+ sera and anti-IgE were inhibited by genistein, and Ca2+/Mg2+ depletion but not by bisindoylmaleimide. HRA(+) sera induced prominent HR from normal basophils with little surface IgE, but induced no increased HR from basophils unresponsive to anti-IgE. Conclusions-Up to 61% of CIU sera will induce increased HR from normal basophils in a sufficiently sensitive assay system. HR induced by most HRA(+) sera is more prominent in basophils with very little surface IgE. However, there may be similar post-binding intracellular activation pathways following stimulation by HRA(+) sera and anti-IgE. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:225 / 234
页数:10
相关论文
共 17 条
[1]   PHARMACOLOGICAL INVESTIGATIONS WITH DIFFERENT PROTEIN-KINASE-C INHIBITORS ON IGE-DEPENDENT AND IGE-INDEPENDENT ACTIVATION OF HUMAN BASOPHILS [J].
AMON, U ;
VONSTEBUT, E ;
WOLFF, HH .
AGENTS AND ACTIONS, 1993, 39 (1-2) :13-19
[2]   INTERLEUKIN-3 AND GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR RENDER HUMAN BASOPHILS RESPONSIVE TO LOW CONCENTRATIONS OF COMPLEMENT COMPONENT-C3A [J].
BISCHOFF, SC ;
DEWECK, AL ;
DAHINDEN, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6813-6817
[3]   Serum IgG autoantibodies directed against the a chain of Fc epsilon RI: A selective marker and pathogenetic factor for a distinct subset of chronic UrtiCaria patients? [J].
Fiebiger, E ;
Maurer, D ;
Holub, H ;
Reininger, B ;
Hartmann, G ;
Woisetschlager, M ;
Kinet, JP ;
Stingl, G .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2606-2612
[4]   DETECTION OF CIRCULATING HISTAMINE RELEASING AUTOANTIBODIES WITH FUNCTIONAL-PROPERTIES OF ANTI-IGE IN CHRONIC URTICARIA [J].
GRATTAN, CEH ;
FRANCIS, DM ;
HIDE, M ;
GREAVES, MW .
CLINICAL AND EXPERIMENTAL ALLERGY, 1991, 21 (06) :695-704
[5]   PLASMAPHERESIS FOR SEVERE, UNREMITTING, CHRONIC URTICARIA [J].
GRATTAN, CEH ;
FRANCIS, DM ;
SLATER, NGP ;
BARLOW, RJ ;
GREAVES, MW .
LANCET, 1992, 339 (8801) :1078-1080
[6]   AUTOANTIBODIES AGAINST THE HIGH-AFFINITY IGE RECEPTOR AS A CAUSE OF HISTAMINE-RELEASE IN CHRONIC URTICARIA [J].
HIDE, M ;
FRANCIS, DM ;
GRATTAN, CEH ;
HAKIMI, J ;
KOCHAN, JP ;
GREAVES, MW .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1599-1604
[7]   DEFECTIVE HISTAMINE-RELEASE IN CHRONIC URTICARIA [J].
KERN, F ;
LICHTENSTEIN, LM .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (05) :1369-1377
[8]   INTRACELLULAR EVENTS IN ANTI-IGE NONRELEASING HUMAN BASOPHILS [J].
KNOL, EF ;
MUL, FPJ ;
KUIJPERS, TW ;
VERHOEVEN, AJ ;
ROOS, D .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (01) :92-103
[9]   THE HETEROGENEITY OF HUMAN IGE EXEMPLIFIED BY THE PASSIVE TRANSFER OF D2O SENSITIVITY [J].
MACDONALD, SM ;
WHITE, JM ;
KAGEYSOBOTKA, A ;
MACGLASHAN, DW ;
LICHTENSTEIN, LM .
CLINICAL AND EXPERIMENTAL ALLERGY, 1991, 21 (01) :133-138
[10]   SIGNAL-TRANSDUCTION - MECHANISMS IN BASOPHILS [J].
MACGLASHAN, D .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (06) :1146-1151